About CDS22 and the De Simone Formulation
CDS22 represents the continuation of over two decades of research into the human gut microbiome. Developed by Professor Claudio De Simone, the CDS22-formula contains the original De Simone Formulation – a unique and scientifically proven combination of eight live bacterial strains designed to restore microbial balance and support long-term digestive health.
The De Simone Formulation has been featured in more than 200 peer-reviewed scientific publications and 80 clinical trials worldwide. Its precision blend of probiotic strains helps maintain gut barrier integrity, support immune modulation, and promote healthy inflammatory responses within the gastrointestinal tract.
Our Mission in New Zealand
Our goal is to bring this internationally trusted probiotic formulation to New Zealand consumers, offering both accessibility and confidence. We believe that better gut health leads to better quality of life, and CDS22 delivers clinically proven support in a safe, natural, and evidence-based way.
Trusted Global Heritage
Previously known under the trademarks VSL#3 and Vivomixx, the CDS22-formula remains the only product that contains the original De Simone Formulation — now available exclusively under the CDS22 brand name in New Zealand.